Prime Therapeutics employees seek professional and personal development with Women’s Health Leadership TRUST membership

Network supports growth, well-being and success of members throughout their leadership journey

July 27, 2022

Prime Therapeutics (Prime) selected five employees for a company-sponsored membership with the Women’s Health Leadership TRUST (the TRUST) based on their leadership attributes, dedication to the health care industry and commitment to advancing women in health care.

Christine Bent, senior vice president and chief operating officer at Prime, serves as the immediate past president on the TRUST’s board of directors. The organization’s mission is to be an inclusive, diverse and collaborative network that advocates, inspires and offers insights to women leaders in health care.

“The TRUST is a great way for women to foster their leadership skills and continue to grow,” Bent said. “It’s exciting that Prime with our Diversity & Inclusion (D&I) Council are giving these employees a development opportunity that contributes to the advancement of women in health care.”

Prime employees new to the TRUST may take advantage of member benefits including networking, professional and personal development and ongoing education and events. Other opportunities include a mentoring program and volunteer committee participation.

Recipients of a one-year membership were nominated by their peers. Member selection was finalized by a review panel of Prime executive and D&I Council leaders.

Prime’s newest members of the TRUST will join the over 400 members that continue to draw on the vision to “Create new possibilities for all women – in health care, well-being and beyond.”

Find out more about Christine’s passion for fostering an environment of sponsorship and the work of the TRUST.

Related news

Stories

May 2, 2024

Prime discusses leading medically integrated dispensing model at Asembia 

Connecting specialty pharmacies and providers to unlock optimal care and value

Stories

April 30, 2024

RECAP: Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2024

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

Stories

April 24, 2024

New study conducted by Prime Therapeutics researchers offers insights into ways to increase equity in health care

Research published in the Journal of Managed Care & Specialty Pharmacy uses population data to fill gaps in social determinants of health data, providing a more complete understanding of a patient’s global health circumstances